Combining IT and OT software to solve manufacturing’s most frequent challenges
PTC and Rockwell Automation combine technologies to accelerate customers’ digital transformation initiatives.
PTC and Rockwell Automation have demonstrated the unparalleled value of their combined technologies, addressing the most costly and persistent challenges manufacturers face today. Enabled by FactoryTalk InnovationSuite, powered by PTC, the companies’ approach simplifies how manufacturers achieve business outcomes that transform operational processes, workforce productivity and efficiency.
Digital transformation, which uses new technology to spur innovation and creativity, has become imperative for manufacturers facing shifting customer expectations, uncertain global trade and cost pressures, and workforce shortages. Despite the many competitive advantages it can provide, less than 10% of industrial companies describe their own digital transformation efforts as a real success, according to LNS Research. Those who are successful have an expansive, company-wide scope and are deploying solutions that tackle broader challenges, such as understanding true performance across facilities with different environments and systems or minimizing unplanned downtime across their organizations.
“Manufacturers today require a new way to approach pressing challenges. That’s why our combined Rockwell Automation and PTC solutions bring together transformational technologies and drive true business outcomes,” said John Genovesi, senior vice president, Enterprise Accounts and Software, Rockwell Automation.
Since becoming strategic partners last year, the two companies have aligned resources, delivered the Factory Talk Innovation Suite, powered by PTC, and won new business in a variety of countries and industries.
“Our collaboration with Rockwell Automation enables industrial enterprises to overcome challenges and gain traction with their digital operations initiatives,” said Howard Heppelmann, general manager, connected operations solutions, PTC. “We are excited to continue offering solutions that streamline the convergence of digital, physical and human elements – all of which are key to helping our customers digitally transform.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance